Outlook Therapeutics, Inc.
(NASDAQ : OTLK)

( )
OTLK PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 3.50%101.030.0%$1484.62m
BIIBBiogen, Inc. -0.32%243.381.7%$644.21m
AMGNAmgen, Inc. -0.43%222.221.3%$567.12m
GILDGilead Sciences, Inc. -0.37%59.891.0%$536.35m
VRTXVertex Pharmaceuticals, Inc. 1.24%217.871.9%$474.35m
REGNRegeneron Pharmaceuticals, Inc. 0.94%523.612.7%$454.22m
BNTXBioNTech SE 2.34%106.500.0%$445.38m
ILMNIllumina, Inc. 0.35%301.853.5%$377.50m
NVAXNovavax, Inc. 8.59%93.9892.9%$336.34m
EXASEXACT Sciences Corp. 4.61%120.5419.6%$304.90m
MGENMiragen Therapeutics, Inc. 0.35%17.300.7%$272.94m
SRRKScholar Rock Holding Corp. -1.57%41.400.0%$245.77m
APVOAptevo Therapeutics, Inc. -0.18%45.5518.3%$228.01m
SGENSeagen Inc. -3.08%168.075.8%$173.40m
ALXNAlexion Pharmaceuticals, Inc. 1.01%122.612.0%$162.56m

Company Profile

Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the identification, development, manufacture, and commercialization of complex biosimilar therapeutics. It focuses on monoclonal antibodies, in the disease areas of immunology and oncology. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Cranbury, NJ.